CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients
CALLY-FS
Prognostic Value of CALLY Index, Frailty and SOFA-2 Score for Mortality in Geriatric Intensive Care Patients: A Prospective Cohort Study
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to evaluate the prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index, Clinical Frailty Scale (CFS), and SOFA-2 score in predicting mortality among geriatric intensive care unit (ICU) patients. The primary outcome is ICU mortality. Secondary outcomes include 28-day mortality, ICU length of stay, duration of mechanical ventilation, need for renal replacement therapy, and vasopressor requirement. The study also investigates whether the combined use of these parameters improves predictive performance compared to conventional scoring systems such as APACHE II.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2026
CompletedStudy Start
First participant enrolled
April 30, 2026
CompletedFirst Posted
Study publicly available on registry
May 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 10, 2026
May 12, 2026
April 1, 2026
2 months
April 30, 2026
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ICU Mortality
All-cause mortality occurring during the intensive care unit stay.
From ICU admission until ICU discharge or death, assessed up to 28 days
Secondary Outcomes (6)
28-day Mortality
28 days
ICU Length of Stay
From ICU admission until ICU discharge or death, assessed up to 28 days
Hospital Length of Stay
From hospital admission until hospital discharge or death, assessed up to 28 days
Duration of Mechanical Ventilation
From initiation of invasive mechanical ventilation until discontinuation, assessed up to 28 days
Vasopressor Requirement
From ICU admission until ICU discharge or death, assessed up to 28 days
- +1 more secondary outcomes
Study Arms (1)
Geriatric ICU patients
Geriatric patients (aged ≥65 years) admitted to the intensive care unit will be included as a single observational cohort. All participants will be evaluated for CALLY index, frailty status, and SOFA-2 score within the first 24 hours of ICU admission.
Interventions
No intervention is applied.This is an observational study in which patients receive standart clinical care.
Eligibility Criteria
Geriatric patients (aged ≥65 years) admitted to the intensive care unit.
You may qualify if:
- Age ≥65 years
- Admission to the intensive care unit
- Availability of required clinical and laboratory data within the first 24 hours of ICU admission
You may not qualify if:
- Death within the first 24 hours after ICU admission
- Missing key clinical or laboratory data
- Terminal malignancy receiving palliative care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başakşehir Çam and Sakura City Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in Anesthesiology and Intensive Care
Study Record Dates
First Submitted
April 30, 2026
First Posted
May 12, 2026
Study Start
April 30, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 10, 2026
Last Updated
May 12, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly available due to institutional and ethical restrictions.